|
2009 Journal Article Midazolam metabolism: Implications for individualised dosing?Roberts, Jason A., Coulthard, Mark G., Addison, Russell S., Foot, Carole and Lipman, Jeffrey (2009). Midazolam metabolism: Implications for individualised dosing?. Journal of Pharmacy Practice and Research, 39 (3), 198-201. doi: 10.1002/j.2055-2335.2009.tb00452.x |
|
2009 Journal Article Tissue Distribution of Beta-Lactam Antibiotics: Continuous versus Bolus DosingRoberts, JA and Lipman, J (2009). Tissue Distribution of Beta-Lactam Antibiotics: Continuous versus Bolus Dosing. Journal of Pharmacy Practice and Research, 39 (3), 219-222. doi: 10.1002/j.2055-2335.2009.tb00457.x |
|
2009 Journal Article Dose matters: Dose of antibiotics in the critically ill patient depends on the dose of renal replacement therapyRoberts, Jason A. and Lipman, Jeffrey (2009). Dose matters: Dose of antibiotics in the critically ill patient depends on the dose of renal replacement therapy. Critical Care Medicine, 37 (8), 2491-2492. doi: 10.1097/CCM.0b013e3181aee840 |
|
2009 Journal Article A systematic review on clinical benefits of continuous administration of [beta]-lactam antibioticsRoberts, Jason A., Webb, Steven, Paterson, David, Ho, Kwok M. and Lipman, Jeffrey (2009). A systematic review on clinical benefits of continuous administration of [beta]-lactam antibiotics. Critical Care Medicine, 37 (6), 2071-2078. doi: 10.1097/CCM.0b013e3181a0054d |
|
2009 Journal Article Pharmacokinetic issues for antibiotics in the critically ill patientRoberts, Jason A. and Lipman, Jeffrey (2009). Pharmacokinetic issues for antibiotics in the critically ill patient. Critical Care Medicine, 37 (3), 840-851. doi: 10.1097/CCM.0b013e3181961bff |
|
2009 Journal Article Piperacillin penetration into tissue of critically ill patients with sepsis - Bolus versus continuous administration?Roberts, Jason A., Roberts, Michael S., Robertson, Thomas A., Dalley, Andrew J. and Lipman, Jeffrey (2009). Piperacillin penetration into tissue of critically ill patients with sepsis - Bolus versus continuous administration?. Critical Care Medicine, 37 (3), 926-933. doi: 10.1097/CCM.0b013e3181968e44 |
|
2009 Journal Article Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distributionRoberts, Jason A., Kirkpatrick, Carl M. J., Roberts, Michael S., Robertson, Thomas A., Dalley, Andrew J. and Lipman, Jeffrey (2009). Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. Journal of Antimicrobial Chemotherapy, 64 (1), 142-150. doi: 10.1093/jac/dkp139 |
|
2009 Journal Article You only find what you look for: The importance of high creatinine clearance in the critically illUdy, A., Roberts, J. A., Boots, R. J. and Lipman, J. (2009). You only find what you look for: The importance of high creatinine clearance in the critically ill. Anaesthesia and Intensive Care, 37 (1), 11-13. doi: 10.1177/0310057x0903700123 |
|
2009 Journal Article Effective dose from cone beam CT examinations in dentistryRoberts, J. A., Drage, N. A., Davies, J. and Thomas, D. W. (2009). Effective dose from cone beam CT examinations in dentistry. British Journal of Radiology, 82 (973), 35-40. doi: 10.1259/bjr/31419627 |
|
2008 Journal Article Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?Roberts, Jason A, Lipman, Jeffrey, Blot, Stijn and Rello, Jordi (2008). Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?. Current Opinion in Critical Care, 14 (4), 390-396. doi: 10.1097/MCC.0b013e3283021b3a |
|
2008 Journal Article Antibiotic resistance - what's dosing got to do with it?Roberts, Jason A., Kruger, Peter, Paterson, David L. and Lipman, Jeffrey (2008). Antibiotic resistance - what's dosing got to do with it?. Critical Care Medicine, 36 (8), 2433-2440. doi: 10.1097/CCM.0b013e318180fe62 |
|
2008 Journal Article Lessons learnt in the pharmacokinetic analysis of the effect of haemoperfusion for acute overdose with sustained-release diltiazemD. M. Roberts, J. A. Roberts, R. J. Boots, R. Mason and J. Lipman (2008). Lessons learnt in the pharmacokinetic analysis of the effect of haemoperfusion for acute overdose with sustained-release diltiazem. Anaesthesia, 63 (7), 714-718. doi: 10.1111/j.1365-2044.2008.05477.x |
|
2008 Journal Article Continuous infusion of time-dependent antibiotics: lung pharmacokinetics and pharmacodynamicsRoberts, Jason A., Paratz, Jennifer D., Paratz, Elizabeth D., Boots, Rob J. and Jeffrey Lipman (2008). Continuous infusion of time-dependent antibiotics: lung pharmacokinetics and pharmacodynamics. Clinical Pulmonary Medicine, 15 (3), 167-172. doi: 10.1097/CPM.0b013e3181729d3d |
|
2008 Journal Article Continuous infusion of [beta]-lactams in the intensive care unit—Best way to hit the target?Jason A. Roberts, Jennifer D. Paratz and Jeffrey Lipman (2008). Continuous infusion of [beta]-lactams in the intensive care unit—Best way to hit the target?. Critical Care Medicine, 36 (5), 1663-1664. doi: 10.1097/CCM.0b013e3181704625 |
|
2008 Journal Article A novel way to investigate the effects of plasma exchange on antibiotic levels: Use of microdialysisRoberts, Jason A., Roberts, Michael S., Robertson, Thomas A., Cross, Sheree E. and Lipman, Jeffrey (2008). A novel way to investigate the effects of plasma exchange on antibiotic levels: Use of microdialysis. International Journal of Antimicrobial Agents, 31 (3), 240-244. doi: 10.1016/j.ijantimicag.2007.09.013 |
|
2007 Journal Article Expanding horizons - needs you to travel over them!Roberts, Jason A. (2007). Expanding horizons - needs you to travel over them!. Journal of Pharmacy Practice and Research, 37 (4), 333-333. doi: 10.1002/j.2055-2335.2007.tb00781.x |
|
2007 Journal Article Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conductedRoberts, Darren M. and Roberts, Jason A. (2007). Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted. Critical Care, 11 (3), 1-2. doi: 10.1186/cc5786 |
|
2007 Journal Article Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot studyRoberts, J. A., Boots, R., Rickard, C. M., Thomas, P., Quinn, J., Roberts, D. M., Richards, B. and Lipman, J. (2007). Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study. Journal of Antimicrobial Chemotherapy, 59 (2), 285-291. doi: 10.1093/jac/dkl478 |
|
2007 Journal Article Cefepime versus ceftazidime: Considerations for empirical use in critically ill patientsRoberts, Jason A., Webb, Steven A. R. and Lipman, Jeffrey (2007). Cefepime versus ceftazidime: Considerations for empirical use in critically ill patients. International Journal of Antimicrobial Agents, 29 (2), 117-128. doi: 10.1016/j.ijantimicag.2006.08.031 |
|
2007 Journal Article Optimizing use of ß-lactum antibiotics in the critically illRoberts, Jason A. and Lipman, Jeffrey (2007). Optimizing use of ß-lactum antibiotics in the critically ill. Seminars in Respiratory and Critical Care Medicine, 28 (6), 579-585. doi: 10.1055/s-2007-996404 |
